Evidence map›Paper›PMID 39829697›Full record

ReviewClinical diabetes : a publication of the American Diabetes Association2025

Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes.

Zeb I Saeed, Halis K Akturk, Grazia Aleppo, Davida Kruger, Carol J Levy, Julia K Mader, Jennifer L Sherr, Viral N Shah

Abstract readReview
In one paragraph

Review in Clinical diabetes : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Registration and Real-Life Studies on Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zeb I SaeedDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA.ORCID https://orcid.org/0000-0002-8195-5890
Halis K AkturkDivision of Endocrinology, Diabetes and Metabolism, Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO.ORCID https://orcid.org/0000-0003-4518-5179
Grazia AleppoDivision of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Davida KrugerDivision of Endocrinology, Diabetes, Bone and Mineral Disease, Henry Ford Health, Detroit, MI.
Carol J LevyDivision of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York, NY.ORCID https://orcid.org/0000-0002-3492-2578
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0001-7854-4233
Jennifer L SherrDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT.ORCID https://orcid.org/0000-0001-9301-3043
Viral N ShahDivision of Endocrinology, Diabetes and Metabolism, Indiana University School of Medicine, Indianapolis, IN.ORCID https://orcid.org/0000-0002-3827-7107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39829697
PMCPMC11739354

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.